Liposome-Mediated Bacterial Ferroptosis-like Death: A Novel Paradigm for Antimicrobial Therapy
Antibiotics · 30.07.2026 · 15 (8) · 738
DOI: 10.3390/antibiotics15080738 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 30.07.2026. Verfasst von Rui Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecule…. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Science and Technology Projects in Guangzhou, Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan University, Science and Technology Projects in Guangzhou.
Abstract (Originalsprache)
The growing global crisis of antimicrobial resistance (AMR) urgently demands non-classical therapies capable of evading established resistance mechanisms. Bacterial ferroptosis-like death, an iron-dependent process driven by lipid peroxidation, offers a promising strategy to circumvent conventional drug resistance. However, the clinical translation of ferroptosis-like inducers is hindered by poor water solubility and off-target systemic toxicity. Featuring tunable physicochemical characteristics and proven clinical biosafety, liposomes stand out as a viable platform to resolve these translational bottlenecks. Although antibacterial nanomedicines have been extensively investigated, the specific synergies between liposomal engineering and bacterial ferroptosis-like pathways remain underexplored. To bridge this gap, this review systematically delineates the molecular cascades of bacterial ferroptosis-like death and highlights unique mechanistic advantages of liposomes. Importantly, liposome-mediated ferroptosis-like antibacterial therapy faces prominent translational challenges, including biosafety concerns, insufficient stability, and targeting limitations. This review further outlines advanced liposomal engineering strategies to tackle the above obstacles and discusses pressing questions that should be the focus of future ferroptosis-like research. By integrating multidisciplinary research outcomes, this review may provide insights and feasible design guidelines to advance the translational development of liposomal ferroptosis-like inducers against AMR infections.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, College of Pharmacy, Jinan Univer…
- Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.
ORCID-Profile: Rui Yang, Xuejuan Zhang
Förderung
- the Science and Technology Projects in Guangzhou
- Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan University
- Science and Technology Projects in Guangzhou
Zitieren
APA
Yang, R., Huang, Z., & Zhang, X. (2026). Liposome-Mediated Bacterial Ferroptosis-like Death: A Novel Paradigm for Antimicrobial Therapy. Antibiotics, 15(8), 738. https://doi.org/10.3390/antibiotics15080738
Vancouver
Yang R, Huang Z, Zhang X. Liposome-Mediated Bacterial Ferroptosis-like Death: A Novel Paradigm for Antimicrobial Therapy. Antibiotics. 2026;15(8):738. doi:10.3390/antibiotics15080738
BibTeX
@article{Yang2026,
author = {Yang, Rui and Huang, Zhengwei and Zhang, Xuejuan},
title = {Liposome-Mediated Bacterial Ferroptosis-like Death: A Novel Paradigm for Antimicrobial Therapy},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {8},
pages = {738},
doi = {10.3390/antibiotics15080738}
}
EUVIMED